Low back pain laboratory findings

Jump to navigation Jump to search

Low back pain Microchapters

Home

Overview

Pathophysiology

Causes

Differentiating Low back pain from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Conservative Management

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Low back pain laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Low back pain laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Low back pain laboratory findings

CDC on Low back pain laboratory findings

Low back pain laboratory findings in the news

Blogs on Low back pain laboratory findings

Directions to Hospitals Treating Low back pain

Risk calculators and risk factors for Low back pain laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Keanu Ngo[2]

Overview

Laboratory testing has no role in the evaluation of nonspecific low back pain (LBP). Tests are used selectively to look for infection, malignancy, inflammatory disease, or nonspinal causes when history or examination raises concern, and to monitor treatment response in spinal infection (Atlas and Nardin, Muscle & Nerve, 2003; Lazzeri et al., Eur J Nucl Med Mol Imaging, 2019).

Indications for testing

  • Not indicated: acute or chronic nonspecific LBP without red flags; routine testing does not change management (Atlas and Nardin, 2003).
  • Consider testing when history or examination suggests: fever, injection drug use, bacteremia or endocarditis, recent spinal procedure or distant infection (infection); prior cancer, unexplained weight loss, age-related risk (malignancy); inflammatory back pain features (axial spondyloarthritis); urinary or abdominal/pelvic features (nonspinal source).
  • Imaging, especially MRI, is the confirmatory test when serious pathology is suspected; laboratory results guide pretest probability and do not replace imaging (Tande et al., N Engl J Med, 2026).

First-line tests when serious pathology is suspected

Test Role Performance and caveats
C-reactive protein (CRP) Preferred marker for suspected spinal infection; also used to monitor treatment Elevated in more than 90% of spondylodiscitis; more sensitive than ESR and responds faster to treatment (Zou et al., Eur J Clin Microbiol Infect Dis, 2025). A normal CRP does not exclude infection (Jo et al., BMC Infect Dis, 2026).
Erythrocyte sedimentation rate (ESR) Screening for infection or malignancy when suspicion is low to moderate Sensitivity 94–100% for infection or malignancy in back pain, specificity low (Lazzeri et al., 2019). Raised by anemia, thyroid disease, and hypoalbuminemia (Jo et al., 2026). Changes slowly.
White blood cell count with differential Part of initial panel Least useful marker; normal in up to 40% of spondylodiscitis (Lazzeri et al., 2019; Boody et al., Curr Rev Musculoskelet Med, 2018).
Blood cultures (before antibiotics) Suspected vertebral osteomyelitis, discitis, or epidural abscess Low sensitivity but a positive result guides antibiotic selection (Boody et al., 2018). Obtain in all suspected spinal infection.

Spinal infection

  • Spinal epidural abscess: the classic triad of focal pain, fever, and neurologic deficit is present in under 20% at diagnosis. Start with leukocyte count, ESR, and CRP; confirmed cases typically have CRP above 100 mg/L and ESR above 60 mm/h. ESR and CRP are nonspecific but reasonably sensitive for ruling out disease; optimal marker and threshold are not established. Gadolinium MRI is the diagnostic test of choice (Tande et al., 2026).
  • Vertebral osteomyelitis/discitis: elevated ESR and CRP are reported in 77–100% (Jo et al., 2026). A CRP of 0.5 mg/dL or below prompts consideration of alternative diagnoses in French Society of Infectious Diseases guidance, though infection is not excluded (Jo et al., 2026).
  • Tuberculous spondylitis is less often associated with elevated inflammatory markers than pyogenic infection (Boody et al., 2018).
  • Treatment monitoring: ESR above 55 mm/h and CRP above 2.75 (units as reported in the source) after 4 weeks of antibiotics were associated with treatment failure (odds ratio 5.15) (Boody et al., 2018).

Malignancy

  • Elevated ESR or CRP is sensitive but nonspecific for spinal metastasis or infection (Montgomery et al., N Engl J Med, 2017).
  • Targeted tests when cancer is suspected, based on clinical context: CBC, calcium, alkaline phosphatase, creatinine, serum protein electrophoresis with free light chains (myeloma), and PSA in men with a suspected prostate primary. Evidence for panel composition in LBP is limited; this is expert practice.

Inflammatory and rheumatologic disease

  • HLA-B27 and CRP support but do not establish axial spondyloarthritis; normal CRP is common. Interpretation belongs in the axial spondyloarthritis chapter.
  • Rheumatoid factor and ANA have no role in LBP without other features.

Nonspinal causes

  • Urinalysis and urine culture: pyelonephritis, nephrolithiasis (hematuria), cystitis.
  • Pregnancy test in persons of childbearing potential before imaging.
  • Lipase, liver tests, troponin, or other organ-specific tests only as directed by the clinical picture (e.g., pancreatitis, cardiac, biliary).
  • Metabolic bone disease: when fragility fracture is found, calcium, phosphate, 25-hydroxyvitamin D, PTH, creatinine, and alkaline phosphatase (details in the osteoporosis literature).

Interpretation pitfalls

  • Normal WBC, ESR, or CRP does not exclude spinal infection, particularly early or with low-virulence organisms (Jo et al., 2026).
  • Elevated inflammatory markers are nonspecific and require imaging correlation.
  • Postoperative CRP rises transiently and is more useful than ESR for monitoring (Zou et al., 2025).

Recommendations

  1. Do not order laboratory tests for nonspecific LBP.
  2. When infection or malignancy is suspected, obtain CBC, CRP, and ESR; add blood cultures before antibiotics if infection is suspected.
  3. Proceed to urgent MRI with contrast when epidural abscess or cord compromise is suspected, regardless of marker results.
  4. Use CRP to follow response to therapy in spinal infection.

Areas of uncertainty

  • Optimal inflammatory marker (CRP vs ESR) and threshold for ruling out infection are not established.
  • Evidence for laboratory panels in suspected malignancy and for routine metabolic testing is limited.

Removed from legacy

  • Placeholder "Please help WikiDoc" text and "Needs content" category.

References

  • Atlas SJ, Nardin RA. Evaluation and treatment of low back pain: an evidence-based approach to clinical care. Muscle & Nerve. 2003.
  • Lazzeri E, et al. Joint EANM/ESNR and ESCMID-endorsed consensus document for the diagnosis of spine infection (spondylodiscitis) in adults. Eur J Nucl Med Mol Imaging. 2019.
  • Zou X, et al. Current knowledge of vertebral osteomyelitis: a review. Eur J Clin Microbiol Infect Dis. 2025.
  • Tande AJ, Currier BL, Osmon DR. Spinal epidural abscess. N Engl J Med. 2026.
  • Jo HJ, et al. Characteristics of infectious spondylitis patients with normal white blood cell count and C-reactive protein level. BMC Infect Dis. 2026.
  • Boody BS, Tarazona DA, Vaccaro AR. Evaluation and management of pyogenic and tubercular spine infections. Curr Rev Musculoskelet Med. 2018.
  • Montgomery MW, et al. Back to the history. N Engl J Med. 2017.

Template:WH Template:WS